Fluidiconic Bio provides tumor‑on‑chip platforms that enable precision oncology research by replicating human tumor physiology in microfluidic devices. Their proprietary MedSelect® platform supports ex vivo drug evaluation, allowing researchers to assess oncology therapeutics and immunotherapies more accurately before clinical trials.
Funding
Funding not disclosed
Founders
Product
Problem
Preclinical oncology research often relies on static cell cultures or animal models that fail to capture the complex fluid dynamics and microenvironment of human tumors, leading to low predictive power for drug efficacy and high attrition rates in clinical trials.
Solution
Fluidiconic Bio offers the MedSelect® tumor‑on‑chip platform, a microfluidic system that recreates key aspects of human tumor physiology, including perfusion, interstitial flow, and cellular heterogeneity. Researchers can culture patient‑derived tumor fragments or organoids within the chip and expose them to candidate therapeutics or immunotherapies under controlled, physiologically relevant conditions. Real‑time readouts of viability, signaling, and immune cell interactions are collected and can be analyzed to rank drug responses before in vivo testing. By providing a scalable ex vivo evaluation tool, the platform aims to increase the translational relevance of preclinical studies and shorten the drug development timeline.
Target Audience
Primary customers are pharmaceutical R&D teams, biotech companies, and academic laboratories conducting preclinical oncology and immunotherapy studies.
Features
- Microfluidic chip design that mimics tumor vascular perfusion and interstitial fluid flow
- Compatibility with patient‑derived tumor explants, organoids, and immune cell co‑cultures
- Integrated sensors and imaging ports for continuous monitoring of viability, metabolism, and immune activity
- Standardized, plug‑and‑play interface allowing rapid setup and reproducible experiments across labs
- Data export compatible with common analysis pipelines and statistical software
- Modular configuration supporting both small‑molecule and biologic therapeutic testing